TriCAM (NCT02976558) - a randomized controlled pilot study of complementary medicine in allogeneic stem cell transplantation to improve quality of life.

BMC Complement Med Ther · 2025 · PMC12418651 · PMID 40922037

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although Qol measured by FACT-G did not reach statistical significance, our data show improvement of transplant related health issues on all subcategories and over the entire study period.

also in 111,027 other papers

showed a trendno p-value reported

TriCAM showed a trend towards mitigating the loss of QoL and significantly reduced depression in patients undergoing aSCT.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.